Form 4: Clorox Director Boosts Stake with Deferred Stock Units

Sentiment:

Insider Transaction Report


Clorox Director Pierre R. Breber acquired additional deferred stock units through dividend reinvestment, annual awards, and in lieu of director fees, increasing his beneficial ownership.

Summary

  • Pierre R. Breber, a Director of The Clorox Company (CLX), reported acquisitions of Deferred Stock Units (DSUs).
  • On November 6, 2025, 8.9351 DSUs were acquired through dividend reinvestment under the Independent Directors' Deferred Compensation Plan.
  • On December 31, 2025, 1,637.8577 DSUs were acquired as an annual award pursuant to the 2005 Stock Incentive Plan.
  • Also on December 31, 2025, 334.7218 DSUs were received in lieu of quarterly director's fees.
  • The Deferred Stock Units will be settled 100% in Clorox common stock upon Breber's retirement or other termination of service as a Director.
  • Following these transactions, Breber's direct beneficial ownership of Deferred Stock Units increased to 2,747.3393.

Sentiment

Score: 7

Explanation: The filing indicates a director's increased beneficial ownership through various compensation mechanisms, aligning their interests with shareholders. This is generally viewed positively as it demonstrates confidence, though it's a routine compensation disclosure rather than a strategic move.

Positives

  • Increased beneficial ownership by a director aligns their interests with those of shareholders, potentially signaling confidence in the company's long-term performance.
  • The acquisition of units through dividend reinvestment and in lieu of fees demonstrates a commitment to holding company equity.

Future Outlook

The Deferred Stock Units acquired by Director Pierre R. Breber are scheduled to be settled 100% in Clorox common stock upon his retirement or other termination of service as a Director.

Industry Context

Director compensation often includes equity awards like Deferred Stock Units to align the interests of board members with long-term shareholder value. These types of disclosures are standard for publicly traded companies.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Compensation Plan UtilizationDeferred Stock Units were acquired under the Independent Directors' Deferred Compensation Plan and the 2005 Stock Incentive Plan, reflecting standard director compensation practices.11/06/2025 and 12/31/2025Reinforces alignment of director incentives with long-term shareholder value through equity-based compensation.

Related Party Transactions

  • Acquisition of Deferred Stock Units by a director as part of their compensation package, including annual awards, dividend reinvestment, and in lieu of cash fees.

Stakeholder Impact

  • Shareholders: Increased alignment of a director's financial interests with long-term shareholder value due to increased equity ownership.
  • Employees: No direct impact mentioned.

Next Steps

  • Settlement of Deferred Stock Units in Clorox common stock upon the reporting person's retirement or termination of service as a Director.

Key Dates

DateDescription
11/06/2025Acquisition of 8.9351 Deferred Stock Units through dividend reinvestment.
12/31/2025Acquisition of 1,637.8577 Deferred Stock Units as an annual award.
12/31/2025Acquisition of 334.7218 Deferred Stock Units in lieu of quarterly director's fees.
01/05/2026Date of filing signature by Attorney-in-Fact.

Keywords

CLX, Clorox, Form 4, Insider Transaction, Director Compensation, Deferred Stock Units, Equity Awards, Corporate Governance

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.